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1. Introduction
Structurally, Carbon nanotubes (CNTs) can be viewed as wrapped from graphene sheets.
Single-walled carbon nanotubes (SWNTs) have one layer of graphene sheet, whereas, the
multiwalled carbon nanotubes (MWNTs) contain multi layers of graphene sheets. The well-
ordered molecular structure brings CNTs many remarkable physical properties, such as, ex‐
cellent mechanic strength, ultrahigh surface area, high aspect ratio, distinct optical
properties [1], and excellent electrical conductivity [2]. In last decade, CNTs are intensively
explored for in-vitro and in-vivo delivery of therapeutics, which was inspired by an impor‐
tant finding that CNTs can penetrate cells by themselves without apparent cytotoxic effect
to the cells [3]. The high aspect ratio makes CNTs outstanding from other types of round
nanoparticles in that the needle-like CNTs allow loading large quantities of payloads along
the longitude of tubes without affecting their cell penetration capability. With the adequate
loading capacity, the CNTs can carry multifunctional therapeutics, including drugs, genes
and targeting molecules, into one cell to exert multi-valence effects. In the other side, owing
to the ultrahigh surface area along with the strong mechanical properties and electrically
conductive nature, CNTs are excellent material for nanoscaffolds and three dimensional
nanocomposites. In recent year, CNT-based devices have been successfully utilized in tissue
engineering and stem cell based therapeutic applications, including myocardial therapy,
bone formation, muscle and neuronal regeneration. Furthermore, owing to the distinct opti‐
cal properties of CNTs, such as, high absorption in the near-infrared (NIR) range, photolu‐
minescence, and strong Raman shift [4], CNTs are excellent agents for biology detection and
imaging. Combined with high surface area of CNTs for attaching molecular recognition
molecules, CNT-based, targeted nanodevices have been developed for selective imaging
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and sensing. There are many areas where CNTs are extremely useful. Given the scope in this
chapter, We describe strategies for preparation of CNTs for their use in medicine. Specifical‐
ly, we focus and highlight the important biomedical applications of CNTs in the field of
drug delivery, gene delivery, stem cell therapy, thermal therapy, biological detection and
imaging (figure 1). The methods for formulating CNT-based therapeutics to suit different
routes of drug administration are also described. The limitations with emphasis on toxicity
and over all future directions are discussed.
Figure 1. Functionalized CNTs in major biomedical applications.
2. Preparation of CNTs for use in medicine
Raw CNTs, persisting metallic nature, are highly hydrophobic. Therefore, surface modifica‐
tion of CNTs, or CNT functionalization, so as to disperse them into aqueous solutions be‐
comes a key step for their biomedical applications. The CNT modification methods are involved
in non-covalent and covalent strategies. The non-covalent modification utilizes the hydropho‐
bic nature of CNTs, especially, π-π interactions for coating of amphiphilic molecules. The
covalent modification generates chemical bonds on carbon atoms on CNT surface via chemi‐
cal reactions followed by further conjugation of hydrophilic organic molecules or polymers
rendering CNTs better solubility. These modifications not only offer CNTs water solubility,
but also produce functional moieties that enable linking of therapeutic agents, such as genes ,
drugs, and recognition molecules for biomedical applications.
Syntheses and Applications of Carbon Nanotubes and Their Composites286
2.1. Non-covalent modification of carbon nanotube surface
The non-covalent modification approaches typically use amphiphilic molecules ranged from
small molecules to polymers. The amphiphilic molecules associate with CNTs by either ad‐
sorbing onto or wrapping the CNTs [5]. The non-covalent modifications of CNTs are easy to
perform. The process is only involved in sonication of CNTs with amphiphilic molecules in
solvent at room temperature. Since it is a mild condition, CNTs molecular structure is not
affected, and therefore their optical and electrical conductive properties are conserved.
Figure 2. Schematic representation of adsorption of amphiphilic molecules onto carbon nanotube surface by π-π
stacking and other hydrophobic interactions. Abbreviations: PL-PEG, phospholipid-polyethylene glycol; PS-b-PAA, pol‐
ystyrene-block-polyacrylic acid.
Adsorption of amphiphilic molecules, such as surfactants, amphiphilic copolymers or oth‐
ers, onto CNT surfaces is one of the simplest and most effective way to disperse CNTs with‐
out destruction of their sp 2 hybridization [5]. The hydrophilic portions of surfactants
interact with the polar solvent molecules, whereas, the hydrophobic portions adsorb onto
the nanotube surface [5, 6]. The dispersity depends strongly on the length of the hydropho‐
bic regions and the types of hydrophilic groups in the amphiphilic molecule. For example,
surfactants with ionic hydrophilic head groups, such as sodiumdodecylsulfate (SDS) [7] or
cetyltrimethyl ammonium bromide (CTAB) [8, 9], can stabilize a nanotube by electrostatic
repulsion between micellar domains [7]. Nonionic surfactants, such as Triton X-100 [8], dis‐
perse CNTs mainly by forming a large solvation shell around a nanotube [8]. Figure 2 illus‐
trates the manor of adsorbing amphiphilic molecules onto CNT surfaces, in which,
hydrophobic alkyl chains or aromatic rings lay flat on graphitic tube surfaces. For example,
an synthetic biocompatible lipid-polymer conjugate, phospholipid-polyethylene glycol (PL-
PEG) has been applied for surface modification of CNTs, which gives rise to a variety of bio‐
medical applications ranged from drug delivery, biomedical imaging, detection and
biosensors [10]. The ionic surfactants, particularly those based on alkyl-substituted imidazo‐
lium cationic surfactants [11], can effectively disperse CNTs in organic or aqueous media by
the counter anion [12, 13]. Polyaromatic derivatives carrying hydrophilic moieties can also
effectively disperse CNTs in aqueous media by forming specific directional π–π stacking
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with the graphitic surfaces of nanotubes [6, 14]. In this context, pyrene, a polyaromatic mole‐
cule, demonstrated a high affinity toward CNT surfaces [6]. Interactions of the polyaromatic‐
moitie of pyrene with CNTs are strong enough to be irreversible, and therefore, the pyrene
derivatives are used to anchor proteins or biomolecules on nanotube surface [6, 14, 15]. Oth‐
er classes of polyaromatic molecules, such as substituted anthracenes, heterocyclic polyaro‐
maticporphyrins [16] and phthalocyanines [17], disperse CNTs via the same mechanism.
The polymers containing hydrophobic backbone and hydrophilic side groups, eg. poly[p-
{2,5-bis(3-propoxysulfonic acid sodium salt)}phenylene] ethynylene (PPES), can effectively
disperse CNTs in water, in which, the strong π– π interactions between CNTs and aromatic
backbone of the polymers drive the wrapping of CNTs, and the water-soluble side groups
impart solubility of CNTs in water [18]. DNA and siRNA can disperse CNTs by wrapping.
DNA or siRNA are made of hydrophobic bases and alternative hydrophilic phosphates and
riboses. Such structure facilitates CNT dispersion by the bases wrapping to CNTs and the
hydrophilic sugar-phosphate groups extending to water phase [19].
2.2. Covalent modification of CNT surface
The covalent modification, namely the chemical modification of CNTs is an emerging area
in materials science. Among the various strategies, the most common ones are:
i. esterification and amidation of oxidized CNTs,
ii. generation of functional groups on CNT sidewalls by cycloaddition reactions.
Oxidation of CNTs is a purification method for raw CNTs. Oxidation of CNTs is carried out
by reflexing raw CNTs in strong acidic media, e.g. HNO3/H2SO4. Under this condition, the
end caps of the CNTs are opened, and carboxylic groups are formed at these ends caps and
at some defect sites on nanotube sidewalls (Figure 3a) [20]. The carboxylic groups provide
opportunities for further derivatization of the CNTs through esterification or amidation re‐
actions. For example, some organic molecules with amine groups can be directly condensed
with the carboxylic groups present on the surface of the CNTs [6, 14]. Alternatively, the car‐
boxyl moieties can be activated with thionyl chloride and subsequent react with amine
groups (Figure 3b) [6, 14]. These reactions are widely applied for conjugation of water-solu‐
ble organic molecules, hydrophilic polymers, nucleic acid (DNA or RNA), or peptides to the
oxidized CNTs, which result in multifunctional CNTs [6, 14]. In most cases, the length of
nanotubes is often shortened [20] ,but the electronic properties of such functionalized CNTs
remain intact. Oxidation reaction only generates carboxyl groups on cap ends and defect
sites on CNTs. To generate chemical bonds on sidewall and cap ends of CNTs, cycloaddition
reactions are used [21](Figure 4). Cycloaddition reaction is a very powerful methodology, in
which the 1,3-dipolar cycloaddition of azomethineylides can easily attach a large amount of
pyrrolidine rings on sidewalls of nanotubes. Thus, the resulting functionalized CNTs are
highly soluble in water [22]. In addition, pyrrolidine ring can be substituted with many
functional groups for different applications.
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Figure 3. Covalent modification of carbon nanotubesby a) Oxidation reaction of cap end of CNTs and b) further at‐
taching hydrophilic molecules by amidation reactions.
In contrast to non-covalent surface modifications, which do not locally disrupt sp 2 hybridi‐
zation, or create defects, the covalent surface modifications disrupt CNT sp 2-conjugated
structures and therefore, could affect the electronic and optical performances [5].
Figure 4. Sidewall covalent modification of carbon nanotubes a) a general scheme of 1,3-dipolar cycloaddition reac‐
tion b) preparation of amino-functionalized CNTs by 1,3-dipolar cycloaddition.
3. Carbon nanotube based therapeutics
3.1. Carbon nanotubes for chemotherapy drug delivery
Cancer is one of the most common causes of death worldwide. Chemotherapy in addition to
the surgical removal of tumors is a conventional treatment for cancers. However, the effec‐
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tiveness of chemotherapy drugs is often limited by the toxicity to other tissues in the body.
This is because most chemotherapy drugs do not specifically kill cancer cells, they act to kill
all cells undergoing fast division. Nanoparticles have been applied to drug delivery and
showed improved drug efficiency and reduced off-target tissue toxicity due to accumulation
in tumor tissues. Nanoparticles target tumor tissues by two mechanisms: passive targeting
and active targeting. As fast growing tissues, tumors display enhanced vascular permeabili‐
ty due to high demand for nutrients and possible oxygen. The features of the leaky vascula‐
ture are employed for delivery of nanoparticle drugs since the size of nanoparticle allows
them to accumulate in tumor tissues [23]. The phenomenon is termed as tumor-selective en‐
hanced permeability and retention (EPR) effect. More efficient tumor targeting can be achieved
through active targeting approaches, in which, targeting molecules can recognize tumor bio‐
markers on cancer cell surface. The properties of CNTs are beneficial for cancer drug deliv‐
ery, firstly, like other nanoparticles, the size of functionalized CNTs is preferable for
accumulation in tumor tissues; secondly, CNTs contain ultrahigh surface area of CNTs facil‐
itate loading of drugs and targeting molecules; thirdly, the hydrophobic benzene ring struc‐
ture of CNTs can be used for loading drugs that contain benzene ring structure, eg.
doxorubicin (DOX), epirubicin (EPI), and daunorubicin (DAU).
Preparation of tumor-targeted devices using carbon nanotubes
A range of tumor targeting molecules has been discovered, including tumor specific anti‐
bodies, peptides, and others. Antibodies have been developed to specifically binding to bio‐
markers on cancer cell surface, eg, Trastuzumab recognizes Human Epidermal Growth
Factor Receptor 2 (HER-2) positive cancer cells[24] and anti-CD20 for CD20 biomarker on B
cell lymphoma [25]. These antibodies have therapeutic effects on their own, and can also
serve as tumor targeting probes. Alpha V beta 3 (αvβ3) integrin is a heterodimerictrans‐
membrane glycoprotein found on a variety of tumor cells, including osteosarcomas, neuro‐
blastomas, glioblastomas, melanomas, lung, breast, prostate cancers. αvβ3) integrin is a
wellrecognized target for cancers. The amino acid sequence of Arg-Gly-Asp (RGD) is identi‐
fied to be responsible for tight binding to αvβ3 integrin, which leads to the development of
short tumor targeting peptide RGD [26]. Similar to RGD, another type of peptide contains
Asn-Gly-Asp (NGR) triad that binds to the endothelium cells on neoangiogenic vessels.
NGR-tagged delivery systems have been developed to deliver cytokines, nanoparticles, and
imaging agents to tumor blood vessels [27]. Folic acid, a small molecule vitamin, binds to
folate receptor overexpressed in a variety of cancer cells, including breast, colon, renal and
lung tumors[28]. As described in section 2 of this chapter, a variety of chemical and physical
methods have been developed for functionalization of CNTs. The above listed tumor target‐
ing molecules are mostly proteins or peptides, which contains sulfhydryl groups that can be
easily conjugated to amino-functionalized CNTs [14] using heterbifunctional linker mole‐
cules that contain NHS ester on one end and Maleimide on the other end [29]. These conju‐
gation reactions are usually carried out under mild conditions [10]. Thus, the molecular
structure of CNTs is not disturbed, and therefore, the optical properties are preserved. The
CNT-based targeted devices developed by this methods are good for potential tumor detec‐
tion and imaging applications. To date, all above-mentioned tumor-targeting strategies have
Syntheses and Applications of Carbon Nanotubes and Their Composites290
been applied for construction of CNT-based, which will be discussed separate in the follow‐
ing sub-sections.
Targeted delivery of chemotherapy drugs by physically absorbed on carbon nanotubes
Supermolecular benzene ring structure of CNTs affords surprisingly high degree of aromat‐
ic molecules by π-π stacking. DOX, an important chemotherapeutic agent, has been effi‐
ciently loaded onto SWNTs-PL-PEG for tumor-targeted delivery [30, 31]. Binding to and
release of drug molecules from nanotubes could be controlled by adjusting pH.The appro‐
priate diameter of nanotube for drug loading was used because the strength of π-π stacking
of aromatic molecules was dependent on nanotube diameter. In-vivo study with SWNTs-
PL-PEG/DOX showed significantly enhanced therapeutic efficacy in a murine breast cancer
model [30]. With further attaching tumor targeting molecules, eg. folic acid (FA) or RGD, the
targeted SWNTs-DOX could more effectively inhibit the growth of cancer cells in-vitro and
in-vivo [31-34]. Similar physical absorption method was applied for drug DAU using
SWNTs, in which, sgc8c Aptamer was used to target leukemia biomarker protein tyrosine
kinase-7 [33]. It has been shown that Aptamer-SWNTs-DAU was able to selectively target
leukemia cells. The release of DAU was pH-dependent.Other hydrophobic drug molecules,
such as paclitaxel (PTX), docetaxel (DTX), can also be absorbed on CNTs surface for delivery
[32, 35], however, their loading efficiency and stability were much lower due to their compa‐
ratively bulky structure.
Targeted delivery of chemotherapy drugs by covalently linked to functionalized carbon nanotubes
Non-aromatic small molecule drugs can be chemically conjugated to CNTs for delivery.
However, the drugmolecules have to be released from the CNTs to take effect, so the linkag‐
es between the drugs and CNTs have to be cleavable. Preferably, the active drugs are re‐
leased inside of the target cells to reduce toxic effect to the neighbouring healthy cells. The
common linkers that are used for drug delivery include ester, peptide, and disulfide bonds.
These linkers can be cleaved by the 7enzymes present in the routes of delivery. Specifically
designed linkers allow controlled release of drug into desired sites. For example, drug cis‐
platin has been conjugated directly to oxidized SWNTs via a peptide linker [36]. This specif‐
ic peptide linkage has been shown tobe selectively cleaved by proteases overexpressed in
tumor cells. Further conjugation of epidermal growth factor (EGF), a growth factor that se‐
lective binding to EGF receptor overexpressed on cancer cells, to SWNTs-cisplatin led to
more efficient tumor inhibition compared to both free cisplatin and non-targeted SWNTs-
cisplatin [36]. Alternative to conjugation of drugs to CNTs directly, drugs can also be conju‐
gated to the molecules, eg. polymers, that are used to disperse CNTs. The end functional
groups in the polymers are used for drug linkage. This method is very useful for delivery of
bulky, hydrophobic drug molecules. In one example, SWNTs was dispersed using a biocom‐
patible polymer PL-PEG-NH2[10] and drug PTX was conjugated to SWNT-PL-PEG-NH2 via
via ester bonding for delivery [37]. PTX is one of the most important drugs for metastatic
breast cancer. However, currently available formulations for PTX have to be infused intrave‐
nously over long periods of time due to the side effects. In addition, due to poor water solu‐
bility of the drug, necessity of use organic solvent, such as Cremophor in clinical
formulation Taxol® causes sever side effects and hypersensitivity reactions [38, 39]. Conju‐
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gation of PTX to SWNTs-PL-PEG-NH2 enable removing of solvent in delivery. Indeed, the
SWNTs-PL-PEG-PTX displayed increased tumor inhibition effect and reduced side effects in
a murine breast cancer model compared with Taxol® formulation [37].
Drugs Targeting Moieties Cancer Biomarkers Type of CNTs References
Cisplatin EGF EGF Receptor SWNTs [36] ]
Daunorubicin Sgc8c Aptamer Tyrosine Kinase-7 SWNTs [33]
Docetaxel NGR Endothelial Cells SWNTs [32]
Doxorubicin Folate /Magnetic Folate Receptor MWNTs [34]
Doxorubicin RGD Integrin αvβ3 SWNTs [30]
Doxorubicin Folate Folate Receptor SWNTs [31, 40]
Gemcitabine Magnetic / MWNTs [41]
Platinum (IV) Folate Folate Receptor SWNTs [42]
Table 1. . Abbreviations: SWNTs, single walled carbon nanotubes; MWNTs, multiwalled carbon nanotubes, EGF,
epidermal growth factor; RGD, peptide with arginine-glycine-aspartate sequence; NGR, peptide with
asparagineglycine - arginine sequence; Sgc8c, oligonucleotide sequence.
3.2. Carbon nanotubes for gene delivery
Gene therapy is an important treatment for cancer and other genetic diseases. However, the
effects of gene therapy are limited by the efficiencies of transfection and system delivery.
Since DNA and siRNA are macromolecules, they cannot pass through cell membrane by
themselves, carriers are needed to take them inside of cells to take effects. Structurally, both
DNA and siRNA contain anionic phosphodiester backbone that and be complexed with cati‐
onic reagents, such as cationic lipids and polymers, etc. For system delivery, the DNA or
siRNA can be loaded into cationic nanoparticles made from cationic lipids or polymers [43,
44]. The nanoparticles could protect them from nucleases degradation. Since CNTs are able
to penetrate cells [3], they are investigated for gene delivery. Typically, two methods are
used for loading nucleic acids to CNTs:
i. electrostatic association with cationic molecule functionalized CNTs [45, 46];
ii. chemical conjugation of nucleic acids to functionalized CNTs via cleavable chemi‐
cal bonds [47];
iii. DNA or siRNA are directly wrap to raw or oxidized CNTs.
Gene delivery using cationic molecule functionalized carbon nanotubes via electrostatic interactions
As discussed early, cationic molecules, such as, ammonium-containing molecules and poly‐
ethylene imine (PEI), can be covalently linked to chemically modified CNTs by oxidation or
1,3-cycloadditions reactions[47-50]. In one application, DNA was loaded into CNTs conju‐
gated with ammonium-terminated oligoethylene glycol(CNTs-OEG-NH3 +) for delivery [47,
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48]. Using this deliver vehicle, expression of test plasmid pCMV-βgal was examined in-vi‐
tro.Result showed that the transfection efficiency of CNTs carrier was 5-10 times higher than
naked DNA; but, much lower than that of liposome [47]. It has been shown that charge ratio
(ammonium groups on CNTs vs phosphate groups of the DNA backbone) is a determination
factor for gene expression [48]. In contrast to DNA delivery, the same CNTs carrier for deliv‐
ery of cyclin A2 siRNA demonstrated pronounced silencing effect in-vitro[51]. Surprisingly,
In-vivo delivery of SOCS1 significantly inhibited SOCS1 expression and retarded the tumor
growth in murine B16 tumor model [52]. The studies with PEI functionalized CNTs also
showed very positive results. PEI is an efficient gene delivery reagent by its own, however,
high amount of PEI is toxic to cells. The siRNA delivery by PEI-grafted MWNTs showed im‐
proved gene expression to the equivalent amounts of PEI polymer alone but with reduced
cytotoxicity [46, 53].
Gene delivery by covalently conjugation to carbon nanotubes via cleavable chemical bonds
Alternatively, genes can be conjugated to amphiphilic polymers that are used for non-cova‐
lent CNT functionalization [10, 54,55]. Incorporation of cleavable chemical bonds facilitates
releasing of DNA or siRNA cargos from CNTs in a controlled manner [54]. Thiol-modified
DNA or siRNA were covalently conjugated to amino group of SWNT-PL-PEG- NH2via cleav‐
able disulfide bond [55]. The genes were released by the cleavage of disulfide bonds by thiol
digesting enzymes upon cellular internalization of CNT-PL-PEG-siRNA. The CNT-mediat‐
ed siRNA delivery showed better gene transfection efficiency than liposome-based delivery
system in hard-to-transfect human T cells and primary cells lines [54].
Gene delivery by wrapping directly on carbon nanotubes
Nucleic acids, DNA or siRNA, contains alternative amphiphilic motifs, which can be used to
disperse CNTs in water. The nucleic acids form helical wrapping around the CNTs with the
bases binding to the hydrophobic CNTs and the hydrophilic sugar-phosphate groups ex‐
tending to the water phase [19]. In this way, DNA or siRNA serves both CNT dispersing
agent and the cargo. It has been shown that the siRNA functionalized SWNTs readily enter
cells and exerts its biological activity in cell culture [19]. Studies with intratumoralinjection
of siRNA functionalized SWNTs showed significantly inhibition effect in-vivo [56].
3.3. Carbon nanotubes for stem cell related therapies
There has been an increasing trend in attempts to design and develop different CNT based
tools and devices for tissue engineering and stem cell therapy applications. In particular,
CNT impregnated nanoscaffolds have shown multiple advantages over currently available
scaffolds. This includes its strong mechanical properties, resemblance of structure with col‐
lagen fibrils and extracellular matrix and electrically conductive nature. These attributes of
the CNT based scaffolds and three dimensional nanocomposites have led to their diverse
therapeutic applications in the field of myocardial therapy, bone formation, muscle and neu‐
ronal regeneration. These applications are mainly based on one principle and that is to mod‐
ulate the stem cell growth and differentiation in a more controlled and desirable manner.
Carbon nanotubes for stem cell based heart therapy
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Over the past two decades there has been significant advancement in stem cell therapy to
repair and replace damaged tissues, such as heart muscle[57]. This is because of their ability
to divide and differentiate into diverse specialized cell types. Recently, there has been in‐
creasing body of evidence indicating that the extracellular matrix plays a critical role in stem
cell viability, proliferation and differentiation [58, 59]. Hence, designing a microenvironment
prepared from polymeric scaffolds which imitate the physical characteristics of natural bio‐
matrix has been the central strategy in tissue engineering. The emergence of nanomaterials
such as nanotubes provide opportunities to design such biocompatible scaffolds for hosting
and directing stem cell differentiation [60].
Preliminary studies demonstrate that neonatal rat ventricular myocytes cultured on sub‐
strates of multiwall carbon nanotubes can interact with the nanofibres by forming tight con‐
tacts and show significantly improved mitotic and chemotactic effects [61]. Moreover, such
mode of culture also altered the electrophysiological properties of cardiomyocytes, indicat‐
ing that CNts are able to promote cardiomyocyte maturation. Further investigations with a
nanocomposite of PLGA:CNF show that cardiomyocyte density increases with greater
amounts of CNF in PLGA [62]. The study also showed similar trends with neurons. The im‐
mense potential of this technology for myocardial therapy roots from the fact that this car‐
diac patch can not only promote myocardial cells, but also induce the nerve cell growth that
help the cardiac cells to contract. In addition, it also supports endothelial cells that make the
inner lining of the blood vessels supplying oxygen to the heart.
Carbon nanotubes for stem cell based bone regeneration
In order to direct stem cell differentiation towards bone regeneration, there has been in‐
creasing interest by the researchers to explore topographical features of the cell culture sub‐
strate. Physical factors, such as rigidity of the extracellular environment, can influence stem
cell growth and differentiation. Such differentiation of human stem cells can be detected by
altering the size of the nanotubes on which the cells are grown [63]. It has been reported that
70- to 100-nm diameter nanotubes can initiate rapid stem cell elongations, which induce cy‐
toskeletal stress and selective differentiation into osteoblast-like cells, offering a promising
route for quicker and better recovery, for example, for patients who undergo orthopedic sur‐
gery. The group also showed that the differentiated stem cells express osteopontin and os‐
teocalcin, the two important osteogenetic protein markers.
Moreover CNTs are promising materials for nanaoscaffold and implantation purposes due
to the fact that CNTs are conductive, have excellent mechanical properties and their nano‐
structured dimensions mimic the 3D structure of proteins found in extracellular matrices.
Their dimensions resembles closely with that of the triple helix of collagen fibrils which can
promote for nucleation and growth of hydroxyapatite, the major inorganic component of
bone. A newly developed nanocomposite scaffold of CNFs/CNTs has been shown to influ‐
ence the cell behaviour [64]. In-vitro study demonstrated that, smaller dimension CNFs dis‐
persed in polycarbonate urethane promoted osteoblast adhesion but did not promote the
adhesion of fibroblasts, chondrocytes, and smooth muscle cells. But the mechanisms that
guide such cell functions are yet to be understood.
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Surface functionalizing the nanotube surface with bone morphogenetic protein-2 (BMP-2)
further accelerates chondrogenic and osteogenic differentiation of MSCs [65, 66]. This stimu‐
lation is a combined effect of the surface nanoscale geometry of the substrate nanostructures
and their BMP-2 coating efficiency. In a similar kind of study, the system also exhibited
higher cell proliferation rate, apart from enhanced differentiation [66]. Nanotubes can also
be used for extended drug release as has been demonstrated by Hu et al, where drug loaded
nanotubes, in combination with multilayers of gelatin and chitosan, have been shown as a
new way to use nanotubes as reservoir for storing drugs [67]. The system effectively pro‐
moted osteoblastic differentiation of MSCs. Further studies in this direction can be beneficial
in order to develop potential bone implants for improved bone osteointegration.
Carbon nanotubes for stem cell based neuronal regeneration
The unique abilities of human embryonic stem cells (hESCs), such as their self-renewal and
potency, hold great promise in the field of regenerative medicine and stem cell based ther‐
apy. The derivation of neuronal lineages from hESCs holds promise to treat neurological
pathologies of the central and peripheral nervous system such as Parkinson’s disease, spi‐
nal cord injury, multiple sclerosis and glaucoma [68, 69]. CNT based substrates have been
shown to promote neuronal  differentiation [70].  It  has also been proposed that  neurons
grown on a  CNT meshwork  displayed better  signal  transmission,  due  to  tight  contacts
between the CNTs and neural  membranes conducible  to electrical  shortcuts  [71].  It  was
demonstrated that the MSCs and the neurosphere of cortex-derived neural stem cells (NSCs)
can grow on the CNT array and both MSCs and NSCs interacted with the aligned CNTs.
The results suggest that CNTs assist in the proliferation of MSCs and aid differentiation of
cortex-derived NSCs [72]. However, due to the harsh external environment in the host body
and lack of supportive substrates during transplantation, much of the transplanted cells lose
its  viability  resulting in reduced therapeutic  efficacy [73].  It  has been reported that  two
dimensional thin film scaffolds, composed of biocompatible poly(acrylic acid) polymer graft‐
ed carbon nanotubes (CNTs), can selectively differentiate human embryonic stem cells in‐
to neuron cells while maintaining the viability of transplanted cells [74]. Even multiwalled
carbon nanotube (MWNT) sheets showed to significantly enhance neural differentiation of
hMSCs grown on the CNT sheets.  Axon outgrowth was also controlled using nanoscale
patterning of CNTs [75]. Recently, silk-CNT-based nanocomposite scaffolds are shown to
protect and promote neuronal differentiation of hESCs [76]. Silks are natural polymers (pro‐
tein) that have been widely used as biomaterials for many years. Fibroin, comprising the
major portion of the silk protein fibre, consists of 90% of amino acids including glycine,
alanine,  and serine.  Due to  its  strong mechanical  and flexible  nature  in  thin  film form,
biocompatibility, and in-vivobioresorbable properties, fibroin protein has been used as the
building block for scaffolds. As confirmed by scanning electron microscope (Figure5 A-C),
similar results were obtained with the developed silk-CNT scaffold where cells grown on
the silk substrate exhibited denser complex three-dimensional axonal bundle networks as
well as better spatial density distribution of the networks compared to other scaffolds. Over‐
all,  the silk-CNT nanocomposite provided an efficient three-dimensional supporting ma‐
trix for stem cell-derived neuronal transplants, offering a promising opportunity for nerve
repair treatments for patients with neurological disorder. In-vitro analysis showed that β-
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III tubulin, representing the mature differentiated neurons and nestin, representing the neu‐
ron precursors, were highly expressed in hESCs grown on the silk-CNT substrate compared
to the expression level of cells grown on the control poly-L-ornithine substrate (figure 5D).
In addition, hESCs cultured on the silk-CNT scaffold exhibited higher maturity along with
dense axonal projections.
Figure 5. Scanning Electron Microscope images of hESCs on various substrates. SEM images of (A) cells cultured on
PLO exhibiting a flat morphology and two-dimensional axonal connections, (B) cells cultured on silk scaffolds demon‐
strating three-dimensional structures and cell migration, and (C) cells cultured on silk-CNT scaffolds demonstrating
three-dimensional axonal connections and silk-CNT matrix degradation. (D) Two neuronal markers (β-III tubulin and
nestin) were used to further determine the hESC differentiation efficiency.Expression intensity of β-III tubulin and nes‐
tin was observed with fluorescence microscopy. Silk-CNT scaffolds exhibited maximum β-III tubulin expression, while
nestin expression exhibited a similar trend. *=P< 0.01, and **= P< 0.001[76]. Abbreviations: PLO, Poly-L-ornithine;
hESCs, human embryonic stem cells; CNT, carbon nanotube.
3.4. Carbon nanotubes for thermal destruction of tumors
Tissues are known to be highly transparent to 700- to 1,100-nm near-infrared (NIR) light,
whereas, SWNTs display strong optical absorbance in this special spectral window. When
constantly absorb energy in NIR region, SWNTs emit heat [77]. Continuous heating leads to
killing of the cells. SWNTs have been engineered with tumor recognition molecules for se‐
lective enteringcancer cells. Upon NIR radiation, the cancer cells were killed by thermal
ablation [78-83]. Previous studies have shown that folic acid decorated SWNTs more effec‐
tively killed folate receptor positive cancer cells [83]; monoclonal antibody (mAb) against
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human CD22 conjugated SWNTsonly targeted CD22(+)CD25(-) Daudi cells; whereas, anti-
CD25 mAb coupled SWNTs only target CD22(-)CD25(+) activated peripheral blood mono‐
nuclear cells [81]. The thermal ablation effects can be combined with other therapies, eg.
chemotherapy, by loading drugs on CNTs for synergic effect [32].
Tumors, in general, contain a small population of tumor initiating stem-like cells, termed as
cancer stem cells. These cells are unmanageable by standard treatment modalities such as
chemotherapy and radiotherapy and tend to persist after treatment [84]. Heat-based cancer
treatments are increasingly becoming a potential alternative to approach this problem. Com‐
bining CNTs with such hyperthermia based therapies can further enhance its efficacy by si‐
multaneously eliminating both the stem cells and bulk cancer cells that constitute a tumor.
In fact, CNTs offer several properties that make them promising candidates for such thermal
therapy. This includes their ability for thermal conductance and strong absorbance of elec‐
tromagnetic radiation. It generates significant amounts of heat upon excitation with near-in‐
frared light which is transparent to biological systems including skins. Such a photothermal
effect can be employed to induce thermal cell death in a noninvasive manner. Thus, if CNTs
can be localized to tumors, they can be stimulated with near-infrared radiation or radiofre‐
quency energy to generate site-specific heat [85]. Preliminary in-vivo results show that a
combination of multiwalled carbon nanotubes (MWNTs) and NIR can be useful for tumor
regression and long-term survival in a mouse model [86]. Such CNT-mediated thermal ther‐
apy addresses the limitations of presently available medical strategies. This includes the
minimally invasive site-specific heating which will greatly diminish the off-target toxicities,
generation of uniform temperature distribution throughout the tumor mass by the activated
CNTs, its compatibility with concurrent MRI temperature mapping techniques. It has also
been recently reported that breast cancer stem cells, highly resistant to conventional thermal
treatments, can be successfully treated with CNT-based photothermal therapies by promot‐
ing necrotic cell death [84]. Further studies in this direction shows that DNA-encased
MWNTs are more efficient at converting NIR irradiation into heat compared to non-encased
MWNTs and that this method can be effectively used in-vivo for the selective thermal abla‐
tion of cancer cells [87].
Glioblastomamultiforme is the most common and aggressive malignant primary brain tu‐
mor involving glial cells and accounting for a large percentage of brain and intracranial tu‐
mor [88, 89]. It is also known for its recurrence and overall resistance to therapy. CD133+
stem cells occurring among GBM cells are responsible for such huge recurrence risk [90]. Re‐
search has been focused on developing strategies to efficiently deliver CNTs to these target
sites, harboring CD133+ cancer stem cells [80]. In-vitro studies show that such targeted elim‐
ination of CD133 (+) cancer stem cells are possible by adding SWNTs functionalized with
CD133 monoclonal antibody, followed by irradiation with NIR laser light. In a separate
study, embryonic stem cells, once administered with MWNTs, have shown to induce an en‐
hanced immune boost and provide subsequent anticancer protection in mice with colon can‐
cer by suppressing the proliferation and development of malignant colon tumors [91].
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4. Carbon nanotubes for biomedical imaging and detection
The well-ordered molecular structure attributes CNTs with multiple distinct optical proper‐
ties, include strong NIR absorption, photoluminescence and Raman shift [92]. Structurally,
SWNTs can be viewed as a cylinder rolled up by one layer of graphene sheet. TThere are
infinite numbers of ways to roll a graphene sheet into a cylinder. Depending on different
ways of wrapping, the particular nanotube could be metallic or semi-conductive. Individual
semi-conductive SWNTs with appropriate chirality can generate a small band gap fluores‐
cence of 1 eV, which corresponds to NIR range (900-1600 nm), where biological tissues have
very low absorption, scattering, and autofluorescence, and therefore, are very useful for bio‐
logical imaging. In the other side, the inherent graphene structure provides SWNTs with
specific Raman scattering signature [93], which is strong enough for use in-vivo imaging. All
these optical properties offer opportunities for SWNTs as contrast agents for near-infrared
(NIR) photoluminescence imaging [94, 95], Raman imaging and optical absorption agent for
photoacoustic imaging [96-98].
4.1. Photoluminescence imaging
NIR photoluminescence of micelle encapsulated SWNTs was firstly discovered by O.Connel
et al [7]. The single-particle dispersion of individual nanotubes was prepared by ultrasoni‐
cally agitating of raw SWNTs in SDS. The tube bundles, ropes, and residual catalyst were
removed by ultracentrifugation, since the aggregation of nanotubes would quench fluores‐
cence. One advantage of the photoluminescence of SWNTs over organic fluorescence dyes is
that SWNTs have no apparent photobleaching, and therefore, the SWNTs could be a power‐
ful tool for tracking changes in living system. Researchers have applied NIR photolumines‐
cence of SWNTs for tracking endocytosis and exocytosis of SWNTs in NIH-3T3 cells in real
time [94, 95]. Moreover, conjugation of antibodies to SWNTs surface allowed specific cell
targeting. They have shown that, with conjugation of anti-CD20, SWNTs selectively recog‐
nized CD20 cell surface receptor on B-cells with little binding to receptor negative T-cells.
Similarly, with conjugation of Herceptin, SWNTs only recognize HER2/neu positive breast
cancer cells. The selective binding of SWNTs was detected by intrinsic NIR photolumines‐
cence of nanotubes. This technique allows deep tissue penetration and high-resolution intra‐
vital microscopy imaging of tumor vessels beneath thick skin [99, 100].
4.2. Raman shift imaging
Raman spectroscopy is a sensitive analytical tool for biological samples. It also has advan‐
tages of resistance to autofluorescence and photobleaching, high spatial resolution, and
small sample size [101]. CNTs exhibit strong resonance Raman scattering with several dis‐
tinctive scattering features including the radial breathing mode (RBM) and tangential mode
(G-band) [93, 102]. Both RBM and G-band of CNTs are sharp and strong peaks, which can
be easily distinguished from autofluorescence of tissue samples, Recently, Raman micro‐
spectroscopy of SWNTs has been applied for imaging of tissue samples, live cells, and small
animal models [96-98]. Tumor targeted delivery by RGD peptide functionalized SWNTs has
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been investigated in murine tumor model [85]. Raman spectroscopy image of excised tissues
confirmed efficient targeting of αvβ3 integrin positive U87MG tumor by RGD [85]. This
study also disclosed that CNTs have relatively long circulation time, and rapid renal clear‐
ance, which makes SWNTs an attractive diagnostic and therapeutic delivery vehicle. Zevale‐
ta et al further developed a Raman microscope capable of noninvasive in-vivo evaluation of
tumors in mice with RGD-labeled SWNTs. Using the dynamic Raman microscope, pharma‐
cokinetics of SWNTs in the tumor was evaluated immediately following an intravenous in‐
jection of SWNTs. Raman spectral analysis revealed effectiveness of the RGD nanotubes to
the integrin expressing U87MG tumor. The noninvasive Raman imaging results were com‐
pared with excised tissues and shows consistency [97].
4.3. Photoacaustic imaging
Photoacoustic imaging is an optical imaging technique that combines high optical absorp‐
tion contrast with diffraction-limited resolution of ultrasonic imaging, which allows deeper
tissues to be viewed in living subjects. In photoacoustic imaging, short pulses of stimulating
radiation are absorbed by tissues, resulting a subsequent thermal expansion and ultrasonic
emission that can be detected by highly sensitive piezoelectric devices. However, many dis‐
eases, for example cancer, in their early stages, do not exhibit a natural photoacoustic con‐
trast, therefore administering an external photoacoustic contrast agent is necessary. Owing
to the strong light absorption characteristic [77], the CNTs can be utilized as photoacoustic
contrast agents. De la Zerdaet. al, in the first time, applied SWNTs for in-vivo imaging of
tumors in mice [103]. In this study, SWNTs was surface modified by PL-PEG and further
conjugated with cyclic RGD peptides for targeting αvβ3 integrin on cancer cells. Intrave‐
nous injection of these cyclic RGD functionalized CNTs to mice bearing tumors showed
eight times stronger photoacoustic signal in the tumors than mice injected with non-targeted
CNTs. This study suggested that photoacoustic imaging using targeted SWNTs could con‐
tribute to non-invasive in-vivo cancer imaging [103]. Similarly, in another study, SWNTs
functionalized with antibody against αvβ3 integrin for photoacoustic imaging of human
glioblastoma tumors in nude mice [104].
5. Selected examples for preparation of carbon nanotube based
therapeutics
In the above CNTs for drug delivery section, we described the functionalization of CNTs
with drugs or targeting molecules. These preparations are usually applied directly via intra‐
venous delivery route, which is the most widely used route of drug administration. Alterna‐
tive to the intravenous drug administration, some other routes of drug administrations are
also important for certain specific applications. Different formulations of CNT-based thera‐
peutics have also been developed to suit the specific routes of administration. Here, we re‐
port several novel cases of CNTs applications for oral and transdermal delivery routes.
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5.1. Carbon nanotube based therapeutics delivery using artificial cells: oral delivery
For many therapeutics, oral and targeted delivery are challenge. One way to deliver them
at the targeted site is by novel methods of encapsulating them in polymeric artificial cells.
Artificial cells are vesicles made by polymeric membranes. They can mimic certain func‐
tions of biological cells. The size of artificial cells ranged from nanometer to hundreds of
micrometer [105]. The membranes of artificial cells are usually semi-permeable that allows
for exchange of small molecules and prevention of passage of large substances across it. Up
to date, artificial cells have been applied for encapsulation biologically active agents, includ‐
ing enzymes,  hormones,  drugs,  even live bacteria  cells  for  in-vivo delivery.  Currently a
couple of artificial cells have been applied clinically [106]. The advantages of artificial cells
include protection of the cargos from immune elimination in the body, targeted delivery of
cargos to desired sites and increasing cargo solubility [106]. In a first feasibility study, func‐
tionalized CNTs have been encapsulated in artificial cell made from biocompatible polymer‐
ic membrane for target specific delivery. The polymeric membrane was assembled with three
layers of polymers, alginate-poly-L-lysine-alginate (APA), via electrostatic association (fig‐
ure 6). Artificial cells protected CNT therapeutics from degradation by the harsh environ‐
ments [107].  PH degradation profile of the polymeric membrane of artificial cells can be
adjusted by composition of polymers, which allows the breakdown of the artificial cells and
release of CNT therapeutics to desired sites. This system is ideal for oral delivery, and can
be used for other delivery routes as well.
Figure 6. Alginate-poly-L-lysine-alginate (APA) microcapsules encapsulatingcarbon nanotubes. The calcium ions are
responsible for cross-linking of the alginate monomeric units trapping the carbon nanotubes into the core of micro‐
capsule [108].
5.2. Carbon nanotube based membrane: transdermal drug delivery
One of the most important areas of transdermal drug delivery (TDD) is in addiction treat‐
ment. Nicotine TDD has been widely used for smoking cessation programs. However, these
traditional transdermal patches could not provide variable drug delivery rates. Some TDD
has the capability to provide variable and programmable delivery rates, however, it needs a
strong electric current across the human skin, which can cause serious skin irritation. Re‐
cently, the membranes prepared by functionalized CNTs have been employed in transder‐
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mal drug delivery. It has been shown that this CNT-membrane was very effective for
treatment of drug abuse and addiction [109]. To prepare the CNT-membrane, MWNTs were
firstly functionalized with negatively charged molecule containing sulphonate (−SO3-) to
have a high charge density on the surface of CNTs, which is necessary to get efficient elec‐
tro-osmosis pumping effect. By this functionalization strategy, CNT-membrane achieves
dramatically fast flow through CNT cores, high charge density, and highly efficient electro‐
phoretic pumping effect. These membranes were the integrated with a nicotine formulation
to obtain switchable transdermal nicotine delivery rates on human skin (in vitro). The trans‐
dermal nicotine formulated CNT-membrane was able to successfully switch between high
level and low level fluxes that coincide with therapeutic demand levels for nicotine cessa‐
tion treatment. These programmable devices cause minimal skin irritation [109].
6. Potentials and limitations of carbon nanotubes in medicine
CNTs are being highly explored in the fields of targeted drug delivery, nanoscaffold for tis‐
sue engineering, biomedical imagining and detecting for disease treatment and health moni‐
toring. The use of CNTs in drug delivery, detection and tissue engineering has shown the
potentials to revolutionize medicine. CNTs affords for a large amounts of payloads for spe‐
cific-targeting and drug delivery. With their intrinsic properties, the CNTs have potential for
building-up multifunctional nanodevices for simultaneous therapeutic delivery and detec‐
tion. Current cancer therapies (eg. radiation therapy, and chemotherapy) are usually painful
and less efficient since they kill normal cells in addition to cancer cells, and therefore, pro‐
ducing adverse side effects and resistance. The CNT-based drug delivery systems have
shown efficient tumor-targeting, and they can effectively kill cancer cells with a dosage low‐
er than conventional drugs used, however significantly reduces side effects. Current CNT-
based nanoscaffolds are very advantages for stem cells therapy in that they can modulate
the stem cell growth and differentiation in a more controlled and desirable manner. Thus,
CNTs have recently gained much interest in the field of medicine.
Although very useful, CNTs exist some limitations. Firstly, pristine CNTs, being metallic in
their nature, are insoluble and they form large bundles or ropes in many solvents, including
water and most solvents, so they cannot be used directly in biomedical applications. Much
work has been done to prepare them for use in medicine. Secondly, the CNTs are not homo‐
genous in their sizes (both diameters and lengths), which could be a problem for generation
of reproducible results that allows evaluation of the biological activity relating to specific
structures. Up to date, tremendous efforts have been put in surface functionalization of
CNTs for use in medicine. This includes numerous effective methods for covalent or non-
covalent modification of CNTs as to disperse them into aqueous solutions and to attach
functional molecules for therapeutic applications. However, in terms of homegenecity of
CNTs. Not much work has been done so far. We propose that attentions are needed to de‐
velop the methods for generation of CNTs with homogeneous size, which is very important
for future clinical applications of CNT-based therapeutics.
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As a novel nanomaterial of great potentials in medicine, the toxicology of CNTs has received
much attention in recent years. Pristine CNTs are very light powders and they can enter the
body through inhalation via the respiratory tract, ingestion via the gastrointestinal tract or,
dermal absorption via the skin. Following entering, CNTs distribute rapidly in the central
and peripheral nervous system, lymphatic and blood circulation and potentially cause toxic
effects in a variety of tissues and organs that they reach, such as heart, spleen, kidney, bone
marrow and liver, etc. Toxicity of CNTs has been evaluated in a variety of cell or animal
models for assessing pulmonary, dermal and immune effects. However, the published re‐
sults have not led to any consensus on the toxicity profile of pristine or functionalized
SWNTs and MWNTs. Some investigators reported that pristine SWNTs that were purified
by acid treatment demonstrated no acute toxicity, as opposed to non-purified CNTs, howev‐
er, they induced reactive oxygen species (ROS) in human lung carcinoma epithelial A549
cells and NR8383 cells [110]. Others demonstrated that pristine SWNTs, either acid-treated
or non-treated, were capable of increasing chromosome and DNA damage, and oxidative
stress in macrophage cell lines [111, 112].
In contrast to raw or acid treated CNTs, the well-dispersed CNTs with high levels of surface
functionalization can reduce the toxicity of MWNTs. One study demonstrated that taurine-
MCWNTs in low and medium doses induced slight and recoverable pulmonary inflamma‐
tion in mice, and are less toxic than raw MCWNTs [113]. This is supported by other studies
indicating that the damage caused by non-PEGylated MWNTs is slightly more severe than
that of PEGylated MWNTs [114]. Furthermore, administrations of high doses of PL-PEG
functionalized SWNTs following intravenous injection did not lead to acute or chronic toxic‐
ity in nude mice, albeit SWNTs persisted within liver and spleen macrophages for 4 months
in mice without apparent toxicity [115] and the SWNTs-PL-PEG were excreted from mice
via the biliary and renal pathways [116]. It is hypothesized that the van der Waals forces on
the surfaces of pristine CNTs cause hydrophobic interactions between CNTs, resulting in ag‐
gregation and network formation, which further induce prolonged toxicity. Thus, function‐
alization of CNTs overcomes the aggregate-forming surface properties of CNTs, and
therefore, reduces toxicity.
7. Conclusions:
CNTs have exhibited diverse physical, chemical and mechanical properties suitable for a va‐
riety of applications. In last decade, biomedical applications of CNTs have undergone rapid
progress. Their unique properties, such as, ultrahigh surface area, high aspect ratio, distinct
optical properties have been applied to develop innovative, multi-functional CNT-based
nanodevices for broad applications. This chapter have described the chemical and physical
methods to prepare CNTs for used in medicine. With these methods, targeting molecules
are attached on CNTs for targeted drug delivery, selective imaging, and other therapies. As
a new type of nanomaterial, the toxicity of CNTs has been extensively investigated. To date,
tremendous toxicity studies on CNTs have been published. However, the published data are
inconsistent. The reason is that CNTs used in these studies vary in dispersion status, size
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and length of tubes, metal impurities and functionalization methods etc. Moreover, different
analysis methods used in the evaluation CNTs toxicity studies also cause disparities. De‐
spite these disparities, there is a broad agreement that well-dispersed CNTs have little or no
toxicity both in-vitro and in-vivo, and therefore are useful for biomedical applications. Final‐
ly, an urgent need has been proposed for long-term studies on the absorption, deposition,
metabolism and excretion (ADME) of CNTs. Only after the uncertainty on CNT toxicity is
resolved, the CNT-based therapeutics can be possible applied clinically.
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